<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-FWDN74Z3</identifier><date>2022</date><creator>Cukjati, Marko</creator><creator>Švajger, Urban</creator><relation>documents/doc/F/URN_NBN_SI_doc-FWDN74Z3_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-FWDN74Z3_001.txt</relation><format format_type="issue">2</format><format format_type="volume">73</format><format format_type="type">article</format><format format_type="extent">str. 79-88</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">107885571</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-FWDN74Z3</identifier><language>slv</language><publisher publisher_location="Ljubljana">Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="eng">advanced therapy medi- cinal products</subject><subject language_type_id="slv">celična terapija</subject><subject language_type_id="eng">cell therapy</subject><subject language_type_id="eng">gene therapy</subject><subject language_type_id="slv">genska terapija</subject><subject language_type_id="slv">zdravila za napredna zdravljenja</subject><title>Advanced therapy medicinal products</title><title>naslednja generacija zdravil</title><title>next generation of medicines</title><title>Zdravila za napredno zdravljenje</title></Record>